Basic Principles of Pharmacology I Flashcards

0
Q

Drug effect

A

Pharmacologic effect= visible response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Drug action

A

Molecular action= invisible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug selectivity

A
  • property of drug to cause a specific effect-few drugs produce a single effect
  • primary effect= desired
  • secondary effect- side effects- may or may not be desired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Interactions of Drug Actions and Effects

A
  • some drugs have a single major mechanism of action and this action produces multiple effects
  • another drug may have several different actions either or both of which are responsible for a single effect and then have an additional action which causes a single effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharmacokinetics

A
  • time course of drug absorption, actions and elimination
  • has to deal with the systemic circulation what is bound and what is free and what is tissue bound
  • and elimination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacodynamics

A
  • types of drug actions
  • physiochemical actions- simple chemical interactions- ie antacids, antiseptics- not very specific
  • receptor interactions- internation of drug with physiologic receptors-macromolecular most drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Basic Sciences and Clinical Medicine of Pharm

A
  • define the physiology of the target tissue: identify the receptors and the endogenous agonists that stimulate the tissue
  • create drugs that mimic the endogenous agonists
  • tests the drugs in the target tissues- laboratory and clinical trials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Doses and weights

A
  • doses are quantities measured by weight (mg, mcg)
  • pharmacodynamic interactions and the pharmcokinetic events occur at the molecular level
  • mg and molecules- mole 6.022 x 10^23
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Receptors

A
  • Macromolecules, particularly proteins. May be on or in a cell or free in the plasma or extracellular fluid
  • these are present as part of the normal biochemical and physiologic mechanisms and usually interact with endogenous compounds. They are specific
  • they function both as ligand binder and as an effector
  • the natural ligand (agnoist) or a drug which resembles it can bind a receptor and modulate its usual activity
  • each receptor occupied might be stimulated (agonist) or inhibited (antagonist)
  • each cell in a tissue contains a large population of receptors that are easily accessible to drugs
  • each drug receptor interaction produces a small change in the biochemical or electrochemical homeostasis of the cell. The cumulative effects of many drug receptor interactions will lead to a change in the function of the cell
  • when enough cells in a tissue are affected then the function of the tissue is altered and an observalbe pharmacologic response can be noted
  • a maximal response is eventually achieved which is related to the number of drug receptor interactions and the physiologic capacity of the tissue (normal vs. diseased)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Types of Receptors

A
  • Membrane bound- eg. in neural synapse, ion channels
  • enzymes- intracellular or extracellular
  • structural macromolcules- eg microtubules
  • intracellular macromolecules- eg steroid receptors, RNA
  • cell membrane itself- change electrical potential fluidity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Regulated by alpha subunits

A
  • alpha s- increase adenylyl cyclase, increase Ca2+
  • alpha i- decrease adenylyl cyclase, increase K+ currents
  • alpha o- decrease Ca2+
  • alpha q- increase phospholipase CB
  • alpha 13- increase Na+/H+ exchange
  • alpha t-increase cGMP-phosphodiesterase (vision)
  • alphaolf- increase adenylyl cyclase (olfaction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Beta subunit regulation

A
  • receptor-operated K+currents
  • adenylyl cyclase
  • phospholipase CB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Reversible Bonds

A
  • Ionic
  • Van der Waals
  • Hydrogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

G proteins

A
  • drug- receptor interations- fractions of seconds activate G protein activity that lasts for seconds
  • G proteins (GTP binding proteins)- regulate the activity of
  • distinct effector proteins in the cell- enzymes, channels, transport proteins
  • there can be multiple G proteins in a single cell
  • act as switches that are turned on by the receptor and turn themselves off in a few seconds
  • several drugs can stimulate different receptors but ultimately influence the same effector protein through the mediation of a G protein that is shared by the different receptors. Thus stimulus averaging or modulation can be achieved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Second Messenger

A
  • also produce amplification of the drug receptor interaction
  • converts an event that happens outside the cell (ie receptor binding) into a change that happens inside the cell-some second messengers can cause different effects in different tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Changing biochemical balance

A
  • changing the biochemical balance of substrates in metabolic pathways and activating or deactivation enzyme systems can have profound effects on the function of the cells in a tissue
  • eg cAMP, Ca2+ may be stimulated or inhibited by G proteins
16
Q

Structure-Activity Relationships

A
  • the structure of the drug determines how it will fit into the receptor
  • the better the fit, the better the stimulation
  • subtle changes in structure amongst a class of drugs can greatly influence the drugs’ effects
  • stereoisomers
17
Q

Quantitative Descriptions of Drug Action

A
  • these are attempts to take experimental data, combine it with certain assumptions and make a model that works for most systems
  • interaction at equilibrium: Drug (D)+ Receptor (R) -> Effect
18
Q

Dose response relationship

A
  • how to measure and compare drug effects
  • you have have dose response curve but also can change it to log dose relationship
  • thresold- the beginning of the curve- dose of agonist at which a response begins. May related to the affinity of the agonist for the receptor
  • slope-rate of rise of the response on the steep portion of the curve, Log of EC50 also relates to affinity
  • maximal asymptote- the top of the curve represents E Max for that particular agonist
19
Q

Receptor Occupancy

A
  • intensity of response is proportional to the fraction of the receptors occupied
  • Effect = Emax [D] / Kd + [D] where Kd= EC 50
  • like enzyme Michaelis-Menton- like enzyme but drug is not consumed as a substrate the macromolecule is one of the reactants and not simply a catalyst
20
Q

Intrinsic Activity

A
  • ability to stimulate the receptor once bound
  • relates to structure and influences efficacy and potency
  • greater intrinsic activity= greater efficacy
21
Q

Spare Receptors

A
  • not all receptors need to be occupied to achieve Emax

- less efficacious agonists may need to occupy more receptors than highly efficacious agonists

22
Q

Secondary Receptors

A

-outside of the target tissues, may mediate other effects of the drug side effects

23
Q

Receptor Regulation

A
  • a cell can up or down regulate a population of receptors by changing the total number of receptors or their sensitivity
  • homeostasis
  • eg denervation hypersensitivity
  • eg desensitization- can occur with down regulation of the receptor or with fatigue or depletion of the intracellular or tissue mechanisms
24
Q

Agonist Drugs

A
  • these bind to the receptor and produce a pharmacologic effect
  • two important events: bind to the receptor and activate receptor after binding
  • better fit to the receptor from more specific structure of the molecule results in more DR and an effect at lower doses
  • in classes of drugs there will be variation in intrinsic activity, based on differences in structure, that will influence the therapeutic effect and use of particular agents
  • 3 different agonists- all able to achieve Emax but with different doses- they differ by binding but not in activating the receptor, all have the same intrinsic activity
  • there can be agonists with different intrinsic activity but the same affinity- these agonists bind to receptor in the same way but differ in activating the receptor
  • two agonists with different intrinsic activity and different affinity
25
Q

Efficacy

A
  • the ability of the drug to activate the effector portion of the receptor once the drug is bound to the receptor
  • depends on the structure of the drug
26
Q

Potency

A
  • relates to the amount of drug that is needed for an effect
  • depends upon: the biologic system: receptor density, efficiency of the stimulus-response mechanisms of the tissue
  • interaction of the drug with the receptor- affinity and efficacy
27
Q

Antagonist Drugs

A
  • many things are learned about the structure and function of receptors from the use of antagonists
  • antagonists can block the binding of agonists and prevent the pharmacologic response
  • therapeutic agents to slow the system down ie paralytic agents
28
Q

Competitive Antagonists

A
  • antagonist effect can be overcome by increasing the dose of the agonist
  • simple competitive antagonist- a simultaneous equilibrium exists for both the agonist and antagonist
  • binding of antagonist to the receptor is a weak bond and easily reversed
29
Q

Noncompetitive Antagonists

A
  • can’t be overcome by increasing doses of agonist
  • receptor remain occupied by antagonist and not enough DR interactions occur to achieve Emax
  • simple explanation of noncompetitive inhibition: binding of antagonist to receptor is a strong bond- such as covalent- and not easily reversed (proton pump inhibitors)
  • the inhibitor can either change the effector or the binding site
30
Q

Noncompetitive Antagonist

A
  • change the effector, does not change binding of drug to the ligand site
  • antagonist alters the effector site
  • even if the ligand binds to the receptor it cannot initiate the effect
  • inhibitor inactivates the effector

-also changes the binding site for the agonist by directly binding to it or by attaching to a different portion of the receptor and altering the agonist binding site